BackRhelion Life Sciences Overview

Rhelion Life Sciences Accounts Payable

Latest accounts payable for TRUFF: $1.5M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.46M
↑ 66.12% YoYΔ $581719.00 vs prior year quarter

Peer trimmed avg / median

Loading

Rhelion Life Sciences Accounts Payable History

Loading

Rhelion Life Sciences vs. peers: Accounts Payable Comparison

Loading

Rhelion Life Sciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rhelion Life Sciences (TRUFF) FAQ

As of the most recent data (June 2026), TRUFF shows a accounts payable of $1.5M. That compares with $880K in the prior-year period — up 66.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRUFF's accounts payable is now $1.5M (was $880K) — a 66.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rhelion Life Sciences is outperforming or lagging.

Tracking TRUFF's accounts payable over time shows whether Rhelion Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $880K in the prior-year period — up 66.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Rhelion Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.5M) with ownership activity and broader fundamentals.

Questions & Answers